Correlation Between Polski Koncern and Ryvu Therapeutics
Can any of the company-specific risk be diversified away by investing in both Polski Koncern and Ryvu Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Polski Koncern and Ryvu Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Polski Koncern Naftowy and Ryvu Therapeutics SA, you can compare the effects of market volatilities on Polski Koncern and Ryvu Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Polski Koncern with a short position of Ryvu Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Polski Koncern and Ryvu Therapeutics.
Diversification Opportunities for Polski Koncern and Ryvu Therapeutics
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Polski and Ryvu is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Polski Koncern Naftowy and Ryvu Therapeutics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ryvu Therapeutics and Polski Koncern is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Polski Koncern Naftowy are associated (or correlated) with Ryvu Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ryvu Therapeutics has no effect on the direction of Polski Koncern i.e., Polski Koncern and Ryvu Therapeutics go up and down completely randomly.
Pair Corralation between Polski Koncern and Ryvu Therapeutics
Assuming the 90 days trading horizon Polski Koncern Naftowy is expected to under-perform the Ryvu Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Polski Koncern Naftowy is 1.74 times less risky than Ryvu Therapeutics. The stock trades about -0.17 of its potential returns per unit of risk. The Ryvu Therapeutics SA is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest 5,270 in Ryvu Therapeutics SA on August 31, 2024 and sell it today you would lose (740.00) from holding Ryvu Therapeutics SA or give up 14.04% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Polski Koncern Naftowy vs. Ryvu Therapeutics SA
Performance |
| Timeline |
| Polski Koncern Naftowy |
| Ryvu Therapeutics |
Polski Koncern and Ryvu Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Polski Koncern and Ryvu Therapeutics
The main advantage of trading using opposite Polski Koncern and Ryvu Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Polski Koncern position performs unexpectedly, Ryvu Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ryvu Therapeutics will offset losses from the drop in Ryvu Therapeutics' long position.| Polski Koncern vs. Drago entertainment SA | Polski Koncern vs. New Tech Venture | Polski Koncern vs. Immobile | Polski Koncern vs. Echo Investment SA |
| Ryvu Therapeutics vs. Echo Investment SA | Ryvu Therapeutics vs. GreenX Metals | Ryvu Therapeutics vs. Cloud Technologies SA | Ryvu Therapeutics vs. Creotech Instruments SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |